Symbols, Society and Satire” reveals a national ambivalence that long predates any particular election result.

I am feeling sad, frustrated, angry and motivated. The way I work, in times like this, is to throw myself into the work and ...

Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. Passage Bio's lead product candidate, PBFT02, ...

WALTHAM, Mass. and DUBLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies ...